<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Fontvieille E</submitter><funding>World Health Organization</funding><pagination>877</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9367082</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>22(1)</volume><pubmed_abstract>&lt;h4>Background&lt;/h4>Breast cancer incidence is increasing rapidly in Latin America, with a higher proportion of cases among young women than in developed countries. Studies have linked inflammation to breast cancer development, but data is limited in premenopausal women, especially in Latin America.&lt;h4>Methods&lt;/h4>We investigated the associations between serum biomarkers of chronic inflammation (interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), leptin, adiponectin) and risk of premenopausal breast cancer among 453 cases and 453 matched, population-based controls from Chile, Colombia, Costa Rica, and Mexico. Odds ratios (OR) were estimated using conditional logistic regression models. Analyses were stratified by size and hormonal receptor status of the t</pubmed_abstract><journal>BMC cancer</journal><pubmed_title>Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study.</pubmed_title><pmcid>PMC9367082</pmcid><funding_grant_id>001</funding_grant_id><pubmed_authors>Garmendia ML</pubmed_authors><pubmed_authors>Biessy C</pubmed_authors><pubmed_authors>Rinaldi S</pubmed_authors><pubmed_authors>Bedoya G</pubmed_authors><pubmed_authors>Echeverri C</pubmed_authors><pubmed_authors>Lin MG</pubmed_authors><pubmed_authors>Cortes B</pubmed_authors><pubmed_authors>Rodriguez AC</pubmed_authors><pubmed_authors>Loria V</pubmed_authors><pubmed_authors>Donn T</pubmed_authors><pubmed_authors>Angel A</pubmed_authors><pubmed_authors>Navionis AS</pubmed_authors><pubmed_authors>Lazcano MF</pubmed_authors><pubmed_authors>Porter PL</pubmed_authors><pubmed_authors>Gonzalez P</pubmed_authors><pubmed_authors>Ocampo R</pubmed_authors><pubmed_authors>Wirtala K</pubmed_authors><pubmed_authors>Diaz-Yunez I</pubmed_authors><pubmed_authors>Cock-Rada A</pubmed_authors><pubmed_authors>Guillen D</pubmed_authors><pubmed_authors>Vial C</pubmed_authors><pubmed_authors>Torres-Mejia G</pubmed_authors><pubmed_authors>Porras C</pubmed_authors><pubmed_authors>Franco LZ</pubmed_authors><pubmed_authors>Navarro E</pubmed_authors><pubmed_authors>Donato E</pubmed_authors><pubmed_authors>Hernandez A</pubmed_authors><pubmed_authors>PRECAMA team</pubmed_authors><pubmed_authors>Moyano L</pubmed_authors><pubmed_authors>Tejeda J</pubmed_authors><pubmed_authors>Herazo F</pubmed_authors><pubmed_authors>Ossa CA</pubmed_authors><pubmed_authors>Angeles-Llerenas A</pubmed_authors><pubmed_authors>Jaramillo R</pubmed_authors><pubmed_authors>Arias WH</pubmed_authors><pubmed_authors>Guenthoer J</pubmed_authors><pubmed_authors>Sanchez GI</pubmed_authors><pubmed_authors>Soto JL</pubmed_authors><pubmed_authors>Cortes YR</pubmed_authors><pubmed_authors>Diaz L</pubmed_authors><pubmed_authors>Fontvieille E</pubmed_authors><pubmed_authors>His M</pubmed_authors><pubmed_authors>Loucks H</pubmed_authors><pubmed_authors>Romieu I</pubmed_authors><pubmed_authors>Alvarado-Cabrero I</pubmed_authors></additional><is_claimable>false</is_claimable><name>Inflammatory biomarkers and risk of breast cancer among young women in Latin America: a case-control study.</name><description>&lt;h4>Background&lt;/h4>Breast cancer incidence is increasing rapidly in Latin America, with a higher proportion of cases among young women than in developed countries. Studies have linked inflammation to breast cancer development, but data is limited in premenopausal women, especially in Latin America.&lt;h4>Methods&lt;/h4>We investigated the associations between serum biomarkers of chronic inflammation (interleukin (IL)-6, IL-8, IL-10, tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), leptin, adiponectin) and risk of premenopausal breast cancer among 453 cases and 453 matched, population-based controls from Chile, Colombia, Costa Rica, and Mexico. Odds ratios (OR) were estimated using conditional logistic regression models. Analyses were stratified by size and hormonal receptor status of the t</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2026-03-27T17:24:35.834Z</modification><creation>2024-11-21T09:50:58.429Z</creation></dates><accession>S-EPMC9367082</accession><cross_references><pubmed>35948877</pubmed><doi>10.1186/s12885-022-09975-6</doi></cross_references></HashMap>